Corient Capital Partners’s Teladoc Health TDOC Stock Holding History

Corient Capital Partners’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,279	Closed	-$237K	–	760
2022 Q1	$237K	Buy	+3,279	New	+$236K	0.02%	629
2021 Q4	–	Sell	-6,057	Closed	-$768K	–	740
2021 Q3	$768K	Buy	6,057 +4,153	+218%	+$605K	0.06%	264
2021 Q2	$317K	Buy	1,904 +18	+1%	+$2.92K	0.02%	477
2021 Q1	$343K	Buy	1,886 +215	+13%	+$49.9K	0.03%	411
2020 Q4	$334K	Buy	1,671 +261	+19%	+$53.1K	0.03%	351
2020 Q3	$309K	Sell	1,410 -11	-0.8%	-$2.33K	0.04%	338
2020 Q2	$271K	Buy	+1,421	New	+$249K	0.03%	362

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Corient Capital Partners's TDOC Position: Q2 2022 in Review

Corient Capital Partners sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,279 shares — an estimated $237K sold.

Corient Capital Partners first reported a position in TDOC in Q2 2020 and held it in 7 quarters. The position peaked at $768K in Q3 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

Corient Capital Partners reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
Corient Capital Partners sold 3,279 Teladoc Health shares in Q2 2022, an estimated $237K.
Corient Capital Partners first reported a position in Teladoc Health in Q2 2020 and held it in 7 quarters.
Corient Capital Partners's Teladoc Health position peaked at $768K in Q3 2021.
551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Corient Capital Partners's 13F filing for Q2 2022, filed 12 Aug 2022.